Fox Chase Cancer Center News

Tarlatamab Shows Efficacy Against Metastatic Small Cell Lung Cancer in Phase 1 Study

PHILADELPHIA (August 8, 2022)—Patients with metastatic small cell lung cancer (SCLC) have limited options for treatment, with few drugs available for patients who have already completed frontline chemotherapy and immunotherapy. Now a global multi-institutional study that included researchers from Fox Chase Cancer Center has shown that the investigational drug tarlatamab is a promising new potential treatment for SCLC.

VIEW STORY

Fels Cancer Institute for Personalized Medicine, Fox Chase Cancer Center, and Thomas Jefferson University to Host Inaugural Symposium on Genome Instability and Personalized Medicine

PHILADELPHIA (August 4, 2022)—The Fels Cancer Institute for Personalized Medicine at the Lewis Katz School of Medicine at Temple University, in partnership with Fox Chase Cancer Center and Thomas Jefferson University, will host a free symposium, “Genome Instability: Discovery to Personalized Medicine.” This event will be held in person on Friday, October 14, 2022, at the DoubleTree by Hilton hotel in Philadelphia.

VIEW STORY

Fox Chase Cancer Center Welcomes Dr. Vanessa B. Wookey

PHILADELPHIA (July 25, 2022)—Fox Chase Cancer Center is pleased to announce the hiring of Vanessa B. Wookey, MD, as an assistant professor in the Gastrointestinal Cancer Program.

Wookey earned her medical degree in 2015 from the Sanford School of Medicine at The University of South Dakota and went on to an internal medicine residency at the University of Nebraska Medical Center. She earned her undergraduate degree in biology from South Dakota State University.

 

VIEW STORY